Professor Dr. Othmar Moser from the University of Bayreuth is the lead author of the new international guideline on exercise ...

A study links undetected diabetes in hemochromatosis patients to increased mortality, highlighting the need for early ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and acceptably safe for the treatment of type 2 diabetes and obesity, leading to ...

Skipping early breakfasts may reduce blood sugar spikes in people with type 2 diabetes, with later breakfast timings showing ...

DexCom Inc (NASDAQ:DXCM) shares up more than 2% following updated guidelines by the American Diabetes Association (ADA), which now recommend using continuous glucose monitors (CGMs) for some adults ...

The global AI in medical diagnostics market is likely to grow from USD 1.71 billion in 2024 to USD 4.72 billion by 2029, at a ...

AstraZeneca's supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive ...

Cardiovascular diseases account for approximately 30% of deaths worldwide and remain a leading cause of morbidity and ...

Valerie J. Parker, DVM, DACVIM (SAIM, Nutrition), talked all about body condition score, muscle condition score, and obesity ...

A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ...

Introduction China faces the dual challenge of high air pollution and an increasing burden of cardiovascular disease (CVD).

As the beginning of the next US presidential administration approaches, the USA faces a series of complex challenges that threaten the health of the American people and the effectiveness and ...